Mereo Biopharma Group PLC
NASDAQ:MREO
Mereo Biopharma Group PLC
Net Change in Cash
Mereo Biopharma Group PLC
Net Change in Cash Peer Comparison
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Mereo Biopharma Group PLC
NASDAQ:MREO
|
Net Change in Cash
-£38m
|
CAGR 3-Years
-63%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Net Change in Cash
-$265.6m
|
CAGR 3-Years
-205%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Net Change in Cash
-$142.4m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Net Change in Cash
$163.7m
|
CAGR 3-Years
24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Net Change in Cash
£40.2m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Net Change in Cash
-£300k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
See Also
What is Mereo Biopharma Group PLC's Net Change in Cash?
Net Change in Cash
-38m
GBP
Based on the financial report for Dec 31, 2022, Mereo Biopharma Group PLC's Net Change in Cash amounts to -38m GBP.
What is Mereo Biopharma Group PLC's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
-63%
The average annual Net Change in Cash growth rates for Mereo Biopharma Group PLC have been -63% over the past three years .